Arvinas (ARVN) Accumulated Expenses (2017 - 2022)
Arvinas (ARVN) recorded quarterly Accumulated Expenses of $30.2 million in Q1 2022, up 30.74% quarter-over-quarter from $23.1 million in Q4 2021, and up 277.44% on a YoY basis from $8.0 million in Q1 2021.
Arvinas (ARVN) Accumulated Expenses (2017 - 2022) Analysis & Trends
Arvinas' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $30.2 million for Q1 2022.
- In Q1 2022, Accumulated Expenses rose 277.44% year-over-year to $30.2 million; the TTM figure through Mar 2022 stood at $30.2 million (up 277.44% YoY), while the FY2021 annual figure was $23.1 million, up 22.22% from the prior year.
- Accumulated Expenses was $30.2 million for Q1 2022 at Arvinas, up from $23.1 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $30.2 million in Q1 2022 to a low of $1.8 million in Q3 2018.
- Historically, Accumulated Expenses has averaged $8.7 million across 5 years, with a median of $4.3 million in 2020.
- The sharpest annual moves came in 2020 and 2021: Accumulated Expenses plunged 33.05% in 2020, then surged 305.43% in 2021.
- A 5-year view of Accumulated Expenses shows it stood at $4.0 million in 2018, then surged by 45.22% to $5.8 million in 2019, then surged by 225.26% to $18.9 million in 2020, then grew by 22.22% to $23.1 million in 2021, then jumped by 30.74% to $30.2 million in 2022.
- The last three Accumulated Expenses figures came in at $30.2 million (Q1 2022), $23.1 million (Q4 2021), and $13.8 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 30.20 Mn |
| Dec 31, 2021 | 23.10 Mn |
| Sep 30, 2021 | 13.77 Mn |
| Jun 30, 2021 | 4.70 Mn |
| Mar 31, 2021 | 8.00 Mn |
| Dec 31, 2020 | 18.90 Mn |
| Sep 30, 2020 | 4.34 Mn |
| Jun 30, 2020 | 2.98 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 5.81 Mn |
| Sep 30, 2019 | 3.68 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 2.95 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Sep 30, 2018 | 1.78 Mn |
| Dec 31, 2017 | 3.55 Mn |